Mortality in peripheral arterial disease: A comparison of patients managed by vascular specialists and general practitioners

Journal of General Internal Medicine

Volumn 22, Issue 5, 2007, Pages 639-644

  Brevetti, Gregorio ^a,b   Oliva, Gabriella ^a   Giugliano, Giuseppe ^a   Schiano, Vittorio ^a   De Maio, Julieta Isabel ^a   Chiariello, Massimo ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b NONE   (Italy)

Author keywords

General practitioners; Mortality; Peripheral arterial disease; Vascular specialists

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTERY DISEASE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; GENERAL PRACTITIONER; HUMAN; LABORATORY; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MORTALITY; PATIENT CARE; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL; COMPARATIVE STUDY; DISEASE MANAGEMENT; MEDICINE; METHODOLOGY; MIDDLE AGED; PERIPHERAL VASCULAR DISEASE; PROSPECTIVE STUDY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PHYSICIANS, FAMILY; PROSPECTIVE STUDIES; SPECIALTIES, MEDICAL;

EID: 34250343397     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-007-0162-z     Document Type: Article

References (27)

1. Schreiber TL, Elkhatib A, Grines CL, O'Neill WW. Cardiologist versus internist management of patients with unstable angina: treatment patterns and outcomes. J Am Coll Cardiol. 1995;26:577-82.
2. Jollis JG, DeLong ER, Peterson ED, et al. Outcome of acute myocardial infarction according to the specialty of the admitting physician. N Engl J Med. 1996;335:1880-7.
3. Abubakar I, Kanka D, Arch B, Porter J, Weissberg P. Outcome after acute myocardial infarction: a comparison of patients seen by specialists and general physicians. BMC Cardiovasc Disord. 2004;4:14.
4. Leng GC, Lee AJ, Fowkes FG, Dunbar J, Housley E, Ruckley CV. Incidence, natural history and cardiovascular events in symptomatic and asymptomatic peripheral arterial disease in the general population. Int J Epidemiol. 1996;25:1172-81.
5. Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med. 1992;326:381-6.
6. Newman AB, Shemanski L, Manolio TA, et al. Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol. 1999;19:538-45.
7. Barletta G, Perna S, Sabba C, Catalano A, O'Boyle C, Brevetti G. Quality of life in patients with intermittent claudication: relationship with laboratory exercise performance. Vasc Med. 1996;1:3-7.
8. Breek JC, Hamming JF, De Vries J, Aquarius AE, van Berge Henegouwen DP. Quality of life in patients with intermittent claudication using the World Health Organization (WHO) questionnaire. Eur J Vasc Endovasc Surg. 2001;21:118-22.
9. Stoffers HE, Rinkens PE, Kester AD, Kaiser V, Knottnerus JA. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol. 1996;25:282-90.
10. Brevetti G, Oliva G, Silvestro A, Scopacasa F, Chiariello M. Peripheral arteriopathy and cardiovascular events (PACE) study group. Prevalence, risk factors and cardiovascular comorbidity of symptomatic peripheral arterial disease in Italy. Atherosclerosis. 2004;175:131-8.
11. Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA. 2001;286:1317-24.
12. McDermott MM, Mehta S, Ahn H, Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med. 1997;12:209-15.
13. Fronek A, Coel M, Berstein EF. Quantitative ultrasonographic studies of lower extremity flow velocities in health and disease. Circulation. 1976;53:957-60.
14. Connors AF Jr, Speroff T, Dawson NV, et al. The effectiveness of right heart catheterization in the initial care of critically ill patients. JAMA. 1996;276:889-97.
15. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
16. Rosenbaum PR, Rubin DB. Reducing bias in observational studies using subclassification on the propensity score. J Am Stat Assoc. 1984;79:516-54.
17. Rossi E, Biasucci LM, Citterio F, et al. Risk of myocardial infarction and angina in patients with severe peripheral vascular disease: predictive role of C-reactive protein. Circulation. 2002;19;105:800-3.
18. Vainas T, Stassen FR, de Graaf R, et al. C-reactive protein in peripheral arterial disease: relation to severity of the disease and to future cardiovascular events. J Vasc Surg. 2005;42:243-51.
19. Vogt MT, McKenna M, Wolfson SK, Kuller LH. The relationship between ankle brachial index, other atherosclerotic disease, diabetes, smoking and mortality in older men and women. Atherosclerosis. 1993;101:191-202.
20. McDermott MM, Kerwin DR, Liu K, et al. Prevalence and significance of unrecognized lower extremity peripheral arterial disease in general medicine practice. J Gen Intern Med. 2001;16:384-90.
21. Greenland P, Abrams J, Aurigemma GP, et al. Prevention conference V: beyond secondary prevention: identifying the high-risk patient for primary prevention: noninvasive tests of atherosclerotic burden: Writing Group III. Circulation. 2000;101:111-6.
22. Darbar D, Gillespie N, Main G, et al. Prediction of late cardiac events by dipyridamole thallium scintigraphy in patients with intermittent claudication and occult coronary artery disease. Am J Cardiol. 1996;78:736-40.
23. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 2002;324:71-86.
24. Narins CR, Zareba W, Moss AJ, et al., for the Thrombogenic Factors and Recurrent Coronary Events (Thrombo) Investigators. Relationship between intermittent claudication, inflammation, thrombosis and recurrent cardiac events among survivors of myocardial infarction. Arch Intern Med. 2004;164:440-6.
25. Schillinger M, Exner M, Mlekusch W, et al. Statin therapy improves cardiovascular outcome of patients with peripheral artery disease. Eur Heart J. 2004;25:742-8.
26. Feringa HH, van Waning VH, Bax JJ, et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol. 2006;47:1182-7.
27. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC working group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31:1-296.